MELLONI, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 6.191
AS - Asia 2.725
EU - Europa 1.957
SA - Sud America 454
AF - Africa 56
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.389
Nazione #
US - Stati Uniti d'America 6.072
SG - Singapore 1.135
CN - Cina 745
IT - Italia 430
BR - Brasile 396
DE - Germania 362
PL - Polonia 271
HK - Hong Kong 267
UA - Ucraina 253
GB - Regno Unito 212
TR - Turchia 182
VN - Vietnam 161
RU - Federazione Russa 94
FI - Finlandia 86
SE - Svezia 73
CA - Canada 66
ID - Indonesia 64
FR - Francia 49
IN - India 39
MX - Messico 38
NL - Olanda 29
ZA - Sudafrica 28
BD - Bangladesh 24
ES - Italia 22
AR - Argentina 21
JP - Giappone 19
LT - Lituania 15
AT - Austria 14
BE - Belgio 14
IQ - Iraq 13
PK - Pakistan 11
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
CO - Colombia 8
EC - Ecuador 8
MA - Marocco 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
CL - Cile 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
PY - Paraguay 6
JO - Giordania 5
EG - Egitto 4
IL - Israele 4
RO - Romania 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
GR - Grecia 3
IR - Iran 3
KE - Kenya 3
TN - Tunisia 3
VE - Venezuela 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NP - Nepal 2
PH - Filippine 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
CH - Svizzera 1
EU - Europa 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 11.389
Città #
Fairfield 708
Ashburn 672
Singapore 623
Woodbridge 560
Houston 484
Chandler 285
Beijing 282
Seattle 277
Santa Clara 270
Hong Kong 267
Warsaw 267
Jacksonville 264
Wilmington 247
Cambridge 237
Dallas 214
Ferrara 188
Ann Arbor 181
Los Angeles 112
Munich 110
Izmir 109
Nanjing 83
New York 81
Princeton 72
San Diego 64
Jakarta 57
Boardman 56
Ho Chi Minh City 51
Milan 38
Shanghai 37
São Paulo 35
Falls Church 33
Hanoi 30
London 29
Buffalo 28
Mexico City 28
Shenyang 25
Chicago 24
Bologna 23
Montreal 23
Nanchang 23
Dong Ket 22
Turku 22
Denver 21
Hefei 21
Dearborn 20
Poplar 20
San Mateo 19
The Dalles 19
Tianjin 19
Brooklyn 18
Johannesburg 18
Orem 18
Stockholm 17
Tokyo 17
Jiaxing 16
Boston 15
Changsha 15
Frankfurt am Main 15
Rio de Janeiro 15
Atlanta 14
Auburn Hills 14
Columbus 14
Hebei 14
Toronto 14
Brussels 13
Bremen 12
Falkenstein 12
Montréal 12
Nuremberg 12
Ankara 11
Chennai 11
Guangzhou 11
Manchester 11
Mountain View 11
Norwalk 11
Council Bluffs 10
Jinan 10
Kunming 10
Moscow 10
Phoenix 10
San Francisco 10
Tappahannock 10
Zhengzhou 10
Curitiba 9
Mumbai 9
Salt Lake City 9
Tashkent 9
Ferrara di Monte Baldo 8
Helsinki 8
Orange 8
Rome 8
Tampa 8
Des Moines 7
Dhaka 7
Elk Grove Village 7
Guarulhos 7
Addison 6
Amsterdam 6
Aprilia 6
Belo Horizonte 6
Totale 7.949
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 260
Targeting mTOR in Acute Lymphoblastic Leukemia 259
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 240
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 233
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 224
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 219
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 215
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 209
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 205
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 195
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 194
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 191
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 189
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 188
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 186
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 186
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 182
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 182
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 177
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 174
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 172
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 165
Eosinophils and purinergic signaling in health and disease 165
Potential role of PKC inhibitors in the treatment of hematological malignancies 163
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 159
Role of CREB transcription factor in c-fos activation in natural killer cells. 154
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 150
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 150
Role of full-length osteoprotegerin in tumor cell biology. 149
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 148
In vitro apoptotic cell death during erythroid differentiation 145
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 143
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 142
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 141
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 135
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 132
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 131
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 128
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 127
Selection and characterization of a novel agonistic human recombinant anti-Trail-R2 minibody with anti-leukemic activity 124
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 123
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. 120
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway 120
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 120
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α promote the NF-κB-dependent maturation of normal and leukemic myeloid cells 119
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 118
Colorectal cancer study with nanostructured sensors: Tumor marker screening of patient biopsies 118
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 116
TRICALCIUM PHOSPHATE STIMULATES ADIPOSE TISSUE-DERIVED STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 114
Role of vitamin D in the pathogenesis of atheromatosis 112
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 108
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 106
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 105
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 101
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids 99
The response of human natural killer cells to interleukin-2. 99
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 98
null 96
Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. 95
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 94
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 94
null 92
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 92
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 91
null 90
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 89
null 89
null 88
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 86
null 84
null 83
Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL 82
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 80
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 77
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 76
null 76
null 76
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 74
null 69
Role of miRNA in adult ocular tumorigenesis 68
MitoQ is able to modulate apoptosis and inflammation 68
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 68
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 66
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 65
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 49
null 45
PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 44
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 43
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 36
Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol 32
null 15
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 11
Totale 11.570
Categoria #
all - tutte 54.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021803 0 0 0 0 0 157 73 134 44 187 130 78
2021/2022764 24 66 50 16 64 51 67 39 28 74 82 203
2022/2023716 83 38 31 78 102 109 39 56 90 7 47 36
2023/2024391 55 32 10 8 28 59 15 40 2 10 16 116
2024/20251.813 46 36 148 87 249 134 71 106 327 170 247 192
2025/20263.156 570 325 488 705 815 253 0 0 0 0 0 0
Totale 11.570